European Organization for Research and Treatment of Cancer (EORTC) Laboratory Research Division workshop on the role of in vivo pre-clinical models in the development of contemporary cancer therapeutics, Verona, Italy, 3 February 2001

Author： EORTC Laboratory Research Division  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.37, Iss.16, 2001-11, pp. : 1976-1980

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quality of life assessment and research in the EORTC (European Organisation for Research and Treatment of Cancer)

By Flechtner H.   Bottomley A.  

Oncologie, Vol. 8, Iss. 5, 2006-06 ,pp. : 443-446

Springer Publishing Company

Access to resources Recommend Favorite

Quality assurance in surgical oncology (QASO) within the European Organization for Research and Treatment of Cancer (EORTC) - current status and future prospects

By Landheer M.L.E.A.   Therasse P.   van de Velde C.J.H.  

European Journal of Cancer, Vol. 37, Iss. 12, 2001-08 ,pp. : 1450-1462

Elsevier

Access to resources Recommend Favorite

Phase II trial with ISIS 5132 in patients with small-cell (SCLC) and non-small cell (NSCLC) lung cancer. A European Organization for Research and Treatment of Cancer (EORTC) Early Clinical Studies Group report

By Coudert B.   Anthoney A.   Fiedler W.   Droz J.P.   Dieras V.   Borner M.   Smyth J.F.   Morant R.   de Vries M.J.   Roelvink M.   Fumoleau P.  

European Journal of Cancer, Vol. 37, Iss. 17, 2001-01 ,pp. : 2194-2198

Elsevier

Access to resources Recommend Favorite

Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923)

By van Rijswijk R.E.N.   Vermorken J.B.   Reed N.   Favalli G.   Mendiola C.   Zanaboni F.   Mangili G.   Vergote I.   Guastalla J.P.   ten Bokkel Huinink W.W.   Lacave A.J.   Bonnefoi H.   Tumulo S.   Rietbroek R.   Teodorovic I.   Coens C.   Pecorelli S.  

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 481-487

Elsevier

Access to resources Recommend Favorite

A cross-validation of the European organization for research and treatment of cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with Lung Cancer

By Kobayashi K.   Takeda F.   Teramukai S.   Gotoh I.   Sakai H.   Yoneda S.   Noguchi Y.   Ogasawara H.   Yoshida K.  

European Journal of Cancer, Vol. 34, Iss. 6, 1998-05 ,pp. : 810-815

Elsevier

Access to resources Recommend Favorite